© Copyright Acquisition International 2026 - All Rights Reserved.

Article Image - Ambulant Health Care Services
Posted 29th February 2016

Ambulant Health Care Services

GlobalCare Clinical Trials, Ltd is the leading global provider of ambulant health care services for clinical trials.

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

Ambulant Health Care Services
Image

Ambulant Health Care Services

GlobalCare Clinical Trials, Ltd is the leading global provider of ambulant health care services for clinical trials. They provide innovative, patient-centric services for biopharmaceutical and medical device companies by conducting selected study visits at locations convenient and comfortable for the patient (e.g., their home, workplace) when travel to the investigator site is not practical.

The firm’s CEO Gail Adinamis is thrilled to have grown this organization from its inception in 2010 to now a global provider in over 45 countries. She is focused on continuing to advance the company’s mission to help advance life-enhancing products to the market by providing high quality, compassionate services and high customer satisfaction.

“This is a great honour and I am quite humbled to have been selected. It is very rewarding to be recognized for my vision and accomplishments over the years” explains the firm’s Gail Adinamis when asked how it feels to have won the CEO of the Year,
the USA award.

“GlobalCare has grown over 50% this past year, much of this is due to repeat client business. We are proud to have been selected as the preferred or exclusive provider for a number of sponsors. We are also excited to have been awarded the Best Ambulant Care Provider for Clinical Trials as well as the International Niche Solutions Provider of the Year in 2015. I have also been named International Game Changer of the Year” she adds.

When asked to explain her career and how she reached her current position as CEO she says she was an accidental entrepreneur and started her career in clinical trials at a big pharmaceutical company. “I was always looking for process  improvements to routine logistics and was able to implement many new innovation logistics. I subsequently looked at improving not only the company’s processes, but the clinical trial process in general” she reveals.

However, Drug development is a long and expensive process taking 10-15 years and over $1 billion to get a new product to market she goes on to say, but in 1992, she was offered an opportunity to create a more patient-centric clinical trial model. “I established and ran a division for a national home infusion company focused on conducting clinical study visits at the patient’s home rather than the
traditional model of patient’s having to travel to the investigational site. From there, I established and headed 2 other wholly owned ubsidiaries for clinical trial services at national home infusion companies” she elaborates.

Continuing the story, in 2004 Adinamis decided to create her own company as it would provide even more flexibility in providing national services for study patients. She continued to push this innovative service model outside the US borders, even into countries ot familiar with home healthcare services. Today, she continues to lead GlobalCare as CEO and has their vision set on continuing to expand their footprint. “I was founder and CEO of GlobalCare since its inception in 2010. I am excited to continue to lead the company with great employees who share the values I established and work towards providing our highest quality and customer service each day” she adds.

In terms of client feedback, “our clients have praised us for our flexibility and team work” Adinamis reveals. Developing this point, she says, “We like to feel like we are a true partner and offer solutions even outside our core business to ensure success of the team and the projects. We have even been quested to rescue studies for clients who were using our competitors. We were glad to successfully provide the services they needed and expected.”

As CEO, the firm’s focus is “ultimately about providing the best patient care” Adinamis continues “With a rapidly growing company, there are challenges to ensure the right and timely hires and to always ensure compliance with our operating procedures. There are peaks and valleys in the work flow – mostly peaks. So it is important to keep the team motivated and focused to provide high quality services on time” she adds.

In closing, the major challenge for GlobalCare Clinical Trials, Ltd in 2016 will be “to keep pace with the rapid influx of new business pportunities and to maintain our high quality of standard.” In addition, staff are key to the success and growth of the company, “so aking the right (or a wrong) hire is critical. I look for not only the credentials of an individual on paper, but the soft skills they possess. You can train an individual on company procedures or study specifics, but you can’t train a person how to be positive and compassionate” Adinamis concludes.





Categories: Innovation


You Might Also Like
Read Full PostRead - Eye Icon
What Is a Public Inquiry and How Will it Affect Your Business?
Legal
21/10/2024What Is a Public Inquiry and How Will it Affect Your Business?

Public inquiries are formal investigations set up to examine events that have caused widespread concern or controversy.

Read Full PostRead - Eye Icon
A Look at Careers with Elevated Risks of Cancer and Occupational Diseases
News
23/08/2024A Look at Careers with Elevated Risks of Cancer and Occupational Diseases

Certain careers pose significant health risks due to inherent job-related hazards. Safety risks such as repeated stress injuries and dangerous chemicals are frequently encountered by workers in these industries. This exposure has the potential to cause major h

Read Full PostRead - Eye Icon
Commercial Law Considerations for Companies Trading Internationally
Legal
08/11/2023Commercial Law Considerations for Companies Trading Internationally

International trade offers significant potential both for businesses and the economy; recent research from Santander suggests UK coffers could benefit to the tune of £93.5bn if SMEs were to realise their global aspirations, while creating an additional 1.9mil

Read Full PostRead - Eye Icon
How to Choose the Right Software Development Firm
Strategy
13/07/2023How to Choose the Right Software Development Firm

In today's digital age, software development is essential to corporate growth and success. Whether you want to create a unique software solution or improve an existing one, selecting the proper software development firm is crucial.

Read Full PostRead - Eye Icon
Coeur Acquisition of Wharf Gold Mine
M&A
27/02/2015Coeur Acquisition of Wharf Gold Mine

Coeur Acquisition of Wharf Gold Mine Coeur Mining, Inc, a precious metals mining company listed on the Toronto and New York Stock exchanges, has acquired the Wharf gold mine located in Lead, South Dakota. The acquisition involved entering into a definitive ag

Read Full PostRead - Eye Icon
Thornton’s Takeover: Ferrero Buys Majority
Finance
23/06/2015Thornton’s Takeover: Ferrero Buys Majority

Ferrero International have successfully completed a takeover bid for the UK-based confectionery store chain.

Read Full PostRead - Eye Icon
Specialized Shipping as Strategic Advantage: The Overlooked Element in Market Expansion Plans
Strategy
01/12/2025Specialized Shipping as Strategic Advantage: The Overlooked Element in Market Expansion Plans

Market expansion entails a comprehensive market analysis, product-market fit, robust strategies and financial forecasting. However, many fail to see logistics as a strategic lever to be maximised. Investing in specialised shipping services is a powerful compet

Read Full PostRead - Eye Icon
Russia’s investment will ensure stable supply of Russian crude through 2021
Finance
02/02/2018Russia’s investment will ensure stable supply of Russian crude through 2021

Russia’s investment will ensure stable supply of Russian crude through 2021

Read Full PostRead - Eye Icon
Ferro Enters into Agreement to Acquire Global Inorganic Pigments Manufacturer Nubiola
Finance
30/04/2015Ferro Enters into Agreement to Acquire Global Inorganic Pigments Manufacturer Nubiola

Ferro Corporation announced today that it has signed a definitive agreement with the shareholders of Barcelona-based Nubiola Pigmentos to acquire 100% of the equity of Nubiola, on a cash-free and debt-free basis, for €146 million.



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow